- 全部删除
 
您的购物车当前为空
SRI-41315 是一种 eRF1 降解剂 ,可在核糖体解码中心充当分子胶。SRI-41315 诱导终止密码子的延长暂停,并抑制永生化和原代人支气管上皮细胞中与囊性纤维化相关的 PTC,恢复 CFTR 表达和功能。SRI-41315 通过降低终止因子 eRF1 的丰度来抑制 PTC。


为众多的药物研发团队赋能,
让新药发现更简单!
SRI-41315 是一种 eRF1 降解剂 ,可在核糖体解码中心充当分子胶。SRI-41315 诱导终止密码子的延长暂停,并抑制永生化和原代人支气管上皮细胞中与囊性纤维化相关的 PTC,恢复 CFTR 表达和功能。SRI-41315 通过降低终止因子 eRF1 的丰度来抑制 PTC。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 386  | In stock | |
| 5 mg | ¥ 913  | In stock | |
| 10 mg | ¥ 1,490  | In stock | |
| 25 mg | ¥ 2,980  | In stock | |
| 50 mg | ¥ 4,790  | In stock | |
| 100 mg | ¥ 6,680  | In stock | |
| 200 mg | ¥ 8,830  | In stock | 
SRI-41315 相关产品
| 产品描述 | SRI-41315 is an eRF1 degrader that acts as a molecular glue at the center of ribosomal decoding.SRI-41315 induces an extended pause at the termination codon and inhibits cystic fibrosis-associated PTC in immortalized and primary human bronchial epithelial cells, restoring CFTR expression and function.SRI-41315 inhibits PTC by decreasing the abundance of the termination factor eRF1 NIOCH 14  | 
| 体外活性 | SRI-41315 在FRT细胞和16HBE14o-细胞中显示出靶细胞毒性(CC50)值均超过50 µM。[1]  | 
| 别名 | SRI41315 | 
| 分子量 | 357.41 | 
| 分子式 | C22H19N3O2 | 
| CAS No. | 1613509-49-1 | 
| Smiles | O=C1C=2C=CC=CC2N(C=3N=C(N(C=4C=CC=CC4)C(=O)C13)C5CCC5)C | 
| 颜色 | White | 
| 物理性状 | Solid | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 16 mg/mL (44.77 mM), Sonication is recommended.   | |||||||||||||||||||||||||
溶液配制表  | ||||||||||||||||||||||||||
DMSO 
  | ||||||||||||||||||||||||||
评论内容